KIKK Capital

Chromodynamics is a deep tech company creating a range of multispectral cameras that can take photos of the composition of materials in real time.

Secret View is a community platform focused on enhancing customer experience through feedback and insights. It enables users to publish their assignments and facilitates a process of becoming proficient feedback providers by offering e-learning, personal support, and quality checks. Additionally, Secret View operates as a market research agency, providing organizations with affordable solutions to continuously learn from real customer experiences. By utilizing mystery shopping research, the company assists retail and hospitality chains in measuring and optimizing their customer service, thereby enhancing overall business performance.

River BioMedics is a biotech company developing 3D human cardiac tissue models for preclinical drug discovery and toxicity screening. These tissues mimic the structure and function of the human heart and provide clinically relevant readouts to assess a compound's effects on cardiac performance and safety. The company uses a stem cell-based, multidisciplinary approach to generate models that support target validation and the discovery and development of novel cardiac therapies.

Pepscope is a Dutch biotechnology company that develops endogenous protein kinase activity profiling technologies, including QuantaKinome, a platform used by pharmaceutical companies and academic researchers to study kinase activity and support the discovery and development of kinase inhibitors and other therapies. The company focuses on profiling protein activity to reveal new applications for existing compounds and to guide therapy development. Its offerings span microarray- and mass spectrometry-based proteomics services and kinase profiling assays, enabling reproducible results and robust longitudinal studies. Founded in 2012 and based in Nijmegen, Pepscope aims to provide actionable proteomics insights to the pharmaceutical industry and researchers.

Toxys is a Dutch biotechnology company specializing in in vitro toxicity screening solutions that help identify hazardous and potential carcinogenic properties of novel compounds. By offering advanced technology that assesses genotoxicity and developmental toxicity, Toxys enables its customers to make informed decisions during the early phases of product and drug development. The company's innovative approach contributes to the creation of safer medicines and products while also aiming to reduce the reliance on animal testing in research and development processes.